Refine Results
- Products
- Content Type
-
Content Type
- Analysis Platform
-
Product
- Language
-
Language
Applied Filters
This application note describes a novel real-time co-culture assay using RTCA eSight for interrogating NK92 immune cell invasion and cytotoxicity and migratory kinetic profiles based on ECM and effects of TME.
- Publication Part Number: 5994-6888EN
- Created: 29 Nov 2023
- 3 MB
This application note evaluates the Agilent xCELLigence RTCA eSight as a tool to monitor BiTE antibody-mediated cancer cell lysis.
- Publication Part Number: 5994-6004EN
- Created: 21 Apr 2023
- 2 MB
Comprising instruments, assay kits, software, and consumables, Agilent Seahorse XF platforms are designed to support you from sample to insight.
- Publication Part Number: 5994-1329EN
- Created: 18 July 2022
- 3 MB
| German (Germany) | Complete (PDF) |
|---|---|
| Russian (Russia) | Complete (PDF) |
| French (France) | Complete (PDF) |
Using the Agilent xCELLigence RTCA eSight to continuously monitor CAR T cell-mediatedkilling of cancer cells over the course of multiplae days.
- Publication Part Number: 5994-1712EN
- Created: 09 Nov 2020
- 4 MB
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
Using the Agilent xCELLigence RTCA system to assess both the selectivity and potency of the TCR-engineered TILs toward HLA restricted cells.
- Publication Part Number: 5994-1771EN
- Created: 25 Mar 2020
- 1 MB
Examines the phosphorylation of signal transducer and activator of transcription (STAT) proteins in response to cytokine stimulation using a phosphoflow technique.
- Publication Part Number: 5994-1030EN
- Created: 01 Nov 2019
- 1 MB
Real-time, kinetic measurements of functional metabolism in cells sourced from blood link mitochondrial function to disease diagnosis and progression.
- Publication Part Number: 5991-7123EN
- Created: 04 Jan 2017
- 643 KB
A real-time assay that quantifies the ATP and biosynthetic demands of immune cell proliferation, differentiation and effector function.
- Publication Part Number: 5991-7128EN
- Created: 22 Dec 2016
- 635 KB
Targeting the immune system has dramatically increased the need for tracking the native, and more recently, engineered phenotypes of multiple cell lineages.
- Publication Part Number: 5994-4703EN
- Created: 17 Aug 2022
- 798 KB
Cytotoxicity is not enough, in vitro assays must also assess persistence and durability. The great challenge of immune cell-based therapies is to safely engineer cells that have enhanced performance character
- Publication Part Number: 5994-4701EN
- Created: 17 Aug 2022
- 2 MB
Although cell therapies have shown great promise in clinical studies, challenges with the large scale manufacturing of these therapies still need to be addressed.
- Publication Part Number: 5994-4702EN
- Created: 17 Aug 2022
- 721 KB
The Agilent NovoCyte Flow Cytometer has become the backbone of the Department of Clinical Immunology lab at Aarhus University Hospital due its ease-of-use and stability.
- Publication Part Number: 5994-4468EN
- Created: 02 May 2022
- 181 KB
An overview of the features of the XF HS miniplate including how it accommodates smaller sample sizes and how this reduction relates to the underlying sensitivity improvements.
- Publication Part Number: 5994-3115EN
- Created: 16 Mar 2021
- 1 MB
| Chinese (Simplified) (China) | Complete (PDF) |
|---|---|
| German (Germany) | Complete (PDF) |
| French (France) | Complete (PDF) |
| Russian (Russia) | Complete (PDF) |
Cytotoxicity is not enough - in vitro assays must assess persistence and durability
- Publication Part Number: 5994-0930EN
- Created: 15 May 2019
- 747 KB
| Italian (Italy) | Complete (PDF) |
|---|---|
| Russian (Russia) | Complete (PDF) |
| Chinese (Simplified) (China) | Complete (PDF) |
| Korean (Korea) | Complete (PDF) |
| French (France) | Complete (PDF) |
| German (Germany) | Complete (PDF) |